By Jackie Syrop
The Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration (FDA) voted 12 to 6 that Lemtrada (alemtuzumab) has demonstrated adequate effectiveness for the treatment of relapsing-remitting multiple sclerosis (MS).
By Katie Eder
The US Food and Drug Administration (FDA) has approved Xiaflex (collagenase clostridium histolyticum) as the first non-surgical treatment for Peyronie’s disease.
By Frank J. Domino, MD
While some low- to moderate-level evidence exists for the short-term use of opioids in low back pain, this well-done systematic review found no evidence to support their long-term use.
By Karla K. Quevedo, MD
Have the Appropriate Use Criteria for transthoracic echocardiography achieved their goal of having a significant clinical impact on physician decision making?
By Jeannette Wick
A researcher from the University of Central Florida Medical School addresses many concerns and misperceptions of fructose-containing sugars.
A candidate inactivated quadrivalent influenza vaccine is efficacious for preventing influenza in young children, according to a study published online Dec. 11 in the New England Journal of Medicine.
Some older women with breast cancer who receive hormone treatment after surgical removal of the tumor can avoid radiotherapy, as radiotherapy has no significant effect on recurrence or survival, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 14 in San Antonio.
For college athletes, head impact exposure is associated with white matter diffusion measures and poorer cognition, even without concussion, according to a study published online Dec. 11 in Neurology.
Apparent disparities between different reviews on the benefit of mammography screening on breast cancer mortality are mainly due to different denominators, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 14 in San Antonio.